Efficacy of albumin in critically ill patients
- 15 March 2003
- Vol. 326 (7389) , 559-560
- https://doi.org/10.1136/bmj.326.7389.559
Abstract
Footnotes Competing interests All four authors are members of the management committee of the SAFE study, which is part funded by CSL Limited. CSL Limited fractionates blood and distributes human albumin and other blood products in Australia, New Zealand, and other countries. A full description of the trial appears on bmj.comKeywords
This publication has 9 references indexed in Scilit:
- Human albumin solution for resuscitation and volume expansion in critically ill patientsPublished by Wiley ,2002
- Patient Survival after Human Albumin AdministrationAnnals of Internal Medicine, 2001
- Whether Albumin Therapy Improves or Worsens Survival of Critically Ill Patients Is Not KnownAnnals of Internal Medicine, 2001
- Human albumin administration in critically ill patients. Analysis is superficial and conclusions exaggerated.1998
- Human albumin administration in critically ill patients. Some patients may benefit.1998
- Albumin: don't confuse us with the factsBMJ, 1998
- Action on human albumin not swift enoughPublished by BMJ ,1998
- Excess mortality after human albumin administration in critically ill patientsBMJ, 1998
- Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not workBMJ, 1998